ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Medmira Inc (PK)

Medmira Inc (PK) (MMIRF)

0.0574
0.00
(0.00%)
Closed November 07 3:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.0574
Bid
0.0131
Ask
0.20
Volume
-
0.00 Day's Range 0.00
0.013 52 Week Range 0.20
Market Cap
Previous Close
0.0574
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
23,085
Shares Outstanding
718,307,062
Dividend Yield
-
PE Ratio
-24.32
Earnings Per Share (EPS)
-0
Revenue
432k
Net Profit
-2.68M

About Medmira Inc (PK)

Sector
In Vitro,in Vivo Diagnostics
Industry
In Vitro,in Vivo Diagnostics
Website
Headquarters
Halifax, Nova Scotia, Can
Founded
-
Medmira Inc (PK) is listed in the In Vitro,in Vivo Diagnostics sector of the OTCMarkets with ticker MMIRF. The last closing price for Medmira (PK) was US$0.06. Over the last year, Medmira (PK) shares have traded in a share price range of US$ 0.013 to US$ 0.20.

Medmira (PK) currently has 718,307,062 shares outstanding. The market capitalization of Medmira (PK) is US$41.23 million. Medmira (PK) has a price to earnings ratio (PE ratio) of -24.32.

MMIRF Latest News

MedMira Wins $4.2 million U.S. Army Contract to Commercialize Rapid Triple Test

MedMira Wins $4.2 million U.S. Army Contract to Commercialize Rapid Triple Test PR Newswire HALIFAX, July 3, 2012 HALIFAX, July 3, 2012 /PRNewswire/ - MedMira Inc., (MedMira) (TSXV: MIR), a...

MedMira Strengthens North American Sales Channels, Adding VWR as Distributor for the United States

HALIFAX, May 28 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and solutions, announced today that...

MedMira Receives FDA Approval for Reveal G3 Rapid HIV Test - Fastest Rapid HIV Test in the US, Delivering Results in Less Than 3

HALIFAX, Oct. 19 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) a global market leader in premium rapid diagnostic solutions, announced today that it has...

MedMira Announces Leadership Transition - Hermes Chan to Succeed Stephen Sham as CEO

HALIFAX, NS, July 24 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) a global market leader in premium rapid diagnostic solutions, announced today that...

MedMira Increases Global Sales Force to Capitalize on Product Approvals

Opportunities in Europe, China, and Developing Nations Being Pursued HALIFAX, June 29 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) a global market leader...

MedMira Completes Acquisition of BAG-1 Technology

HALIFAX, May 25 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in premium rapid diagnostic solutions, announced today that it has...

China SFDA Approves MedMira's Whole Blood Rapid HIV Test

Approval Opens Point-of-Care and Home Testing Markets in China HALIFAX, May 17 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in...

MedMira Grows Rapid HIV Test Sales in Latin America

Receives Product Registration and Initial Order for Argentina HALIFAX, April 20 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in...

MedMira Acquires Technology to Develop New Tests for Cancer

Emerging Cancer Markers Commercialized Through Maple Biosciences HALIFAX, April 3 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader...

MedMira Files Patent for Over-the-Counter Testing System

Home HIV Test First in MedMira's New Self-Care Product Line HALIFAX, March 23 /PRNewswire-FirstCall/ -- MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF) the global market leader in...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0004-0.6920415224910.05780.05780.0574144700.05748639CS
4-0.0004-0.6920415224910.05780.05780.0549277160.05710463CS
120.0443338.1679389310.01310.05780.013230850.04791767CS
26-0.0026-4.333333333330.060.090.013186410.04286015CS
520.015436.66666666670.0420.20.013142460.04623019CS
156-0.03493-37.83169067480.092330.219050.002162900.0853368CS
2600.0573573000.00010.63690.0001562400.23865271CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DEERDeer Consumer Products Inc (CE)
US$ 0.001
(99,900.00%)
65.1k
THBDThird Bench Inc (PK)
US$ 0.0003
(29,900.00%)
458.55M
REPCFRepliCel Life Sciences Inc (CE)
US$ 0.0002
(19,900.00%)
100
KGJIKingold Jewelry Inc (CE)
US$ 0.0001
(9,900.00%)
24.52k
PPJEPPJ Healthcare Enterprises Inc (PK)
US$ 0.0001
(9,900.00%)
5.12M
MLYCFMulti Metal Development Ltd (CE)
US$ 0.000001
(-100.00%)
160k
CSSEQChicken Soup for the Soul Entertainment Inc (CE)
US$ 0.000001
(-99.92%)
2k
EKCSElectronic Control Security Inc (CE)
US$ 0.000001
(-99.83%)
239
SPBVSports Pouch Beverage Company Inc (CE)
US$ 0.000001
(-99.50%)
3.95k
INTKIndustrial Nanotech Inc (PK)
US$ 0.000001
(-99.00%)
3.13M
THBDThird Bench Inc (PK)
US$ 0.0003
(29,900.00%)
458.55M
HMBLHUMBL Inc (PK)
US$ 0.0003
(0.00%)
190.04M
SAPXSeven Arts Entertainment Inc (PK)
US$ 0.0002
(-33.33%)
171.8M
RDARRaadr Inc (PK)
US$ 0.0008
(-11.11%)
139.73M
SPRVSupurva Healthcare Group Inc (PK)
US$ 0.0001
(0.00%)
138M

MMIRF Discussion

View Posts
Chrism0000 Chrism0000 11 months ago
Anyone still own this shit show??
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $0.2 ? 0.0 (0.00%)
Volume: 0 @-
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
Time to load up with these shares, stock is rock solid at these levels.
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $0.23469 ^ 0.00969 (4.31%)
Volume: 73,425 @02/19/21 3:48:17 PM EST
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $0.25234 ? 0.0 (0.00%)
Volume: 0 @-
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
The dip is in from .52 good entry point at .35
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
Big day tomorrow.
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
BREAKOUT .43 cents up 68%

News pending
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
Stock trades quite heavy under their Canadian ticker symbol MIR.V
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
Waiting for a news release
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $0.17897 ^ 0.00251 (1.42%)
Volume: 1,500 @01/06/21 9:30:22 AM EST
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
11,442,248 shares traded in Canada under the ticker symbol MIR.v Dec31, 2020 and 169,000 shares traded in America under the ticker symbol MMIRF.

Going to be a whole bunch of news and developments this first quarter of 2021..........stay tuned
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
Medmira going to all time highs this year........2021 is the year of the breakout for MMIRF / MIR.v
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $.20 with news
πŸ‘οΈ0
shajandr shajandr 4 years ago
Oh what a scam!!!
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
NEWS RELEASE: Product update, looks like a new bull run will start today with no end in sight

https://www.globenewswire.com/news-release/2020/12/31/2151927/0/en/MedMira-Announces-Product-Update.html

πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $0.1843 v -0.0057 (-3.00%)
Volume: 118,175 @12/16/20 2:54:18 PM EST
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $0.1959 v -0.002864 (-1.44%)
Volume: 9,020 @12/11/20 1:01:40 PM EST
Bid Ask Day's Range
0.198764 0.198764 0.194588 - 0.1959
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
revenue way up, stock going to run
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $0.2204 ^ 0.01647 (8.08%)
Volume: 41,255 @11/25/20 3:59:17 PM EST
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $0.19139 ^ 0.01491 (8.45%)
Volume: 63,100 @11/19/20 3:02:33 PM EST
Bid Ask Day's Range
- - 0.172831 - 0.19802
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $0.177 v -0.021 (-10.61%)
Volume: 46,811 @11/09/20 3:25:15 PM EST
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $.50 with news
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $0.212863 v -0.003137 (-1.45%)
Volume: 17,450 @10/30/20 10:18:53 AM EDT
πŸ‘οΈ0
shajandr shajandr 4 years ago
Oh what a SCAM!
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $0.22093 v -0.00907 (-3.94%)
Volume: 400 @10/22/20 12:05:10 PM EDT
πŸ‘οΈ0
Steve1978 Steve1978 4 years ago
Need that FDA stamp of approval... so quite
πŸ‘οΈ0
Chrism0000 Chrism0000 4 years ago
NEWS!!! LETS GO!!! :)))))))
πŸ‘οΈ0
Chrism0000 Chrism0000 4 years ago
NEWS!!! LETS GO!!! :)))))))
πŸ‘οΈ0
Steve1978 Steve1978 4 years ago
Quick Covid-19 Test are back in the forefront of news!!! IMHO FDA Approval Right Around the Corner!
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $0.2076 v -0.000462 (-0.22%)
Volume: 12,415 @10/02/20 2:16:31 PM EDT
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$mmirf $0.2164 v -0.00391 (-1.77%)
Volume: 14,617 @09/29/20 2:45:15 PM EDT
πŸ‘οΈ0
Steve1978 Steve1978 4 years ago
Surprised FDA approval is still pending... any second now
πŸ‘οΈ0
Steve1978 Steve1978 4 years ago
Copied from another board

We had such an incredible afternoon today at MedMira Inc. Laboratory in #ClaytonParkWest!

#MedMira has come out with a patent for #COVID19 that can detect if you have antibodies within minutes, and will show the results for days to follow (which is something that is not common with these types of tests).

Just a few short months ago, 6 months to be exact, MedMira only had 11 staff members. Today, the company has expanded to 54 people! It was truly amazing to see all of their employees who come from over 18 countries; there are 6 summer students and over 30 new immigrants.

The expansion of staff is due to the high demand for their REVEALCOVID-19 TM Total Antibody test.

One of the most valuable things we noticed is that these individuals are extremely hard-working. This job is an exceptional way for them to get the Canadian working experience and to have flourishing and enriching careers!

We felt a true sense of family and community β€” this is the real beauty of Canada; There is opportunity and space for everyone to work in harmony.

The staff at MedMira contribute a weekly production of over 20,000 COVID-19 tests. We are told that the external performance evaluation of this product in the United States has been exceptional.

They also plan to expand to other markets, such as Europe and Asia.

Please stay tuned for a special feature from my office, highlighting a behind-the-scenes look at MedMira Inc.

Thank you to Hermes Chan (CEO) and Markus Meile (CFO), for your information breakdown of the antibody test. As well as all the exciting things your company is doing and plans to do in the future.

We wish you the best of luck!
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
Should be a green day today
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
Just a few short months ago, 6 months to be exact, MedMira only had 11 staff members. Today, the company has expanded to 54 people! It was truly amazing to see all of their employees who come from over 18 countries; there are 6 summer students and over 30 new immigrants.

GREAT WRITE UP FROM CANADIAN POLITICIAN

https://www.facebook.com/134268600446739/posts/808411506365775/?extid=gZpJa2yakqi1gWjA&d=n
πŸ‘οΈ0
Steve1978 Steve1978 4 years ago
Need the FDA approval... anytime now
πŸ‘οΈ0
Steve1978 Steve1978 4 years ago
FDA Approval ANYDAY!!! Best Test on the Market!! !
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
stock looking good today
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
New German report puts a target price of $1.50 to $1.75 on MedMira short term and $3 a share long-term. Thanks in part to their latest news release on September 3.

https://www.wallstreet-online.de/nachricht/12902844-medmira-vorwaerts-lang-wars-ruhig-medmira-artikel-globe-newswire-facht-spekulation-an
πŸ‘οΈ0
Steve1978 Steve1978 4 years ago
Yep very nice day for Medmira
πŸ‘οΈ0
Chrism0000 Chrism0000 4 years ago
PRICE?? :))))
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
FDA will approve before months end. From today's news release it can be seen our tests meet the FDA criteria. Good luck tomorrow
πŸ‘οΈ0
Chrism0000 Chrism0000 4 years ago
WHO IS THE DICK !! THAT PUT THAT CRAP UP TOP OF PAGE AZZ!!!
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
ALIFAX, Nova Scotia, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) reports findings to further emphasize the high sensitivity of REVEALCOVID-19β„’ Total Antibody Test 7 days post symptom onset as well as highlights the test’s zero cross-reactivity (i.e. no false positive results) with HIV positive samples.

https://ca.finance.yahoo.com/news/revealcovid-19-total-antibody-test-210000021.html
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
NEWS RELEASE SEPTEMBER 3, 2020 after market close:

https://ca.finance.yahoo.com/news/revealcovid-19-total-antibody-test-210000021.html
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
But they can sell during the review period.......I think tomorrow is going to be a good day for the stock, with the run to .38 a few days ago and today's close at the high
πŸ‘οΈ0
Steve1978 Steve1978 4 years ago
I agree... just seems like the FDA is delaying potential the best test available (medmira) while approving Abbott test that are less accurate.
πŸ‘οΈ0
Paraceratherium Paraceratherium 4 years ago
Think it is overdue, but I read that they are extra vigilant due to their past acceptance of less than adequate tests in the initial panic. Hermes Chan just posted on linked in (from stockhouse post):

The study reveals key finding about specific IgM, IgG1, and IgA1 antibody not only present in plasma or serum of almost all analyzed COVID-19 convalescent study subjects, most significantly is that these antibodies were also detected at exceptionally early stages of the infection (i.e., 7-8 days after disease onset).

This may set a new criteria and create great opportunity for serological tests used in screening convalescent plasma for the emergency therapeutic application critical for treating severe COVID-19 patients.
πŸ‘οΈ0
Steve1978 Steve1978 4 years ago
Any clue about the delay of fda approval?
πŸ‘οΈ0